Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18853431 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1CYP1A1CYP1B1 | |
| SCHEMBL18853402 | 0.89 | ATM (0.37) | KDM4EATML3MBTL1CYP1A1CYP1B1 | |
| SCHEMBL18853349 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4ALDH1A1 | |
| SCHEMBL18853227 | 0.87 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4PTGES | |
| SCHEMBL16905628 | 0.86 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL23983787 | 0.86 | KDM4E (0.33) | KDM4EATML3MBTL1PTGER4PTGES | |
| SCHEMBL18852944 | 0.85 | KDM4E (0.38) | KDM4EATML3MBTL1CYP1A1CYP1B1 | |
| SCHEMBL18853397 | 0.85 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL20068433 | 0.84 | CYP1A1 (0.36) | ATMCYP1A1CYP1B1GAACYP1A2 | |
| SCHEMBL18853415 | 0.84 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10680190-B2 | Organic compound, organic optoelectronic element, and display device | SAMSUNG SDI CO., LTD. (KR) | 2020-06-09 | — | — | US | disclosed |
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO.,LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO.,LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | OCIAD1, OXER1, OCIAD2 | KDM4E 3232/4885ATM 4486/4885L3MBTL1 3198/4885 |
| US-10680190-B2 | Organic compound, organic optoelectronic element, and display device | OCIAD1, OXER1, OCIAD2 | KDM4E 3232/4885ATM 4486/4885L3MBTL1 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.